An Italian biopharmaceutical company
The company is focused on the discovery, development and commercialization of monoclonal antibodies
MP-PN-1
Cell surface component
This monoclonal antibody recognizes a cell surface differentiation antigen of yet unknown function, that is selectively expressed in a subtype of human monocytic leukemia.
Besides its use as a diagnostic tool, MP-PN-1 can be exploited as a therapeutic antibody.
MediaPharma s.r.l. P.IVA.: IT 02282760699 | Rea di Chieti: 166532
The information provided on www.mediapharma.it is designed to complement, not replace, the relationship between a patient and his/her own physician.
